Publications by authors named "Aleksandra Babnis"

Although viruses subvert innate immune pathways for their replication, there is evidence they can also co-opt anti-viral responses for their benefit. The ubiquitous human pathogen, Herpes Simplex Virus-1 (HSV-1), encodes a protein (UL12.5) that induces the release of mitochondrial nucleic acid into the cytosol, which activates immune sensing pathways and reduces productive replication in non-neuronal cells.

View Article and Find Full Text PDF
Article Synopsis
  • Mammalian innate immune pathways utilize nucleotide-based second messengers like 2'3'-cGAMP and 2'-5' oligoadenylates (OAs) to activate key proteins STING and RNase L, indicating an evolutionarily conserved mechanism to trigger antiviral responses.
  • A study using mass spectrometry found several members of the ABCF protein family in various species, highlighting their role as 2'-5' OA-binding proteins, with ABCF1 showing high-affinity binding to phosphorylated 2'-5' OA.
  • Despite these interactions, the research did not find strong antiviral functions in the ABCF proteins or Decr1, suggesting that 2'-5' OAs may act primarily as signaling hubs, necess
View Article and Find Full Text PDF

Understanding the molecular mechanisms of herpes simplex virus 1 (HSV-1) latent infection and reactivation in neurons requires the use of model systems. Establishing a quiescent infection in cultured neurons is problematic, as any infectious virus released can superinfect the cultures. Previous studies have used the viral DNA replication inhibitor acyclovir to prevent superinfection and promote latency establishment.

View Article and Find Full Text PDF

Herpes simplex virus (HSV) establishes latent infection in long-lived neurons. During initial infection, neurons are exposed to multiple inflammatory cytokines but the effects of immune signaling on the nature of HSV latency are unknown. We show that initial infection of primary murine neurons in the presence of type I interferon (IFN) results in a form of latency that is restricted for reactivation.

View Article and Find Full Text PDF

Viruses pose substantial challenges for society, economy, healthcare systems, and research. Their distinctive pathologies are based on specific interactions with cellular factors. In order to develop new antiviral treatments, it is of central importance to understand how viruses interact with their host and how infected cells react to the virus on a molecular level.

View Article and Find Full Text PDF

Transporter associated with antigen processing (TAP), a key player in the major histocompatibility complex class I-restricted antigen presentation, makes an attractive target for viruses that aim to escape the immune system. Mechanisms of TAP inhibition vary among virus species. Bovine herpesvirus 1 (BoHV-1) is unique in its ability to target TAP for proteasomal degradation following conformational arrest by the UL49.

View Article and Find Full Text PDF